Atsushi Aoyagi

1.3k total citations
19 papers, 1.0k citations indexed

About

Atsushi Aoyagi is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Atsushi Aoyagi has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Neurology. Recurrent topics in Atsushi Aoyagi's work include Prion Diseases and Protein Misfolding (9 papers), Neurological diseases and metabolism (5 papers) and Alzheimer's disease research and treatments (5 papers). Atsushi Aoyagi is often cited by papers focused on Prion Diseases and Protein Misfolding (9 papers), Neurological diseases and metabolism (5 papers) and Alzheimer's disease research and treatments (5 papers). Atsushi Aoyagi collaborates with scholars based in Japan, United States and United Kingdom. Atsushi Aoyagi's co-authors include Stanley B. Prusiner, Amanda L. Woerman, Smita S. Patel, William W. Seeley, Lefkos Middleton, Steven H. Olson, Sabeen A. Kazmi, Kurt Giles, Joel C. Watts and Abby Oehler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Atsushi Aoyagi

18 papers receiving 998 citations

Peers

Countries citing papers authored by Atsushi Aoyagi

Since Specialization

Citations

This map shows the geographic impact of Atsushi Aoyagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Aoyagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Aoyagi more than expected).

Fields of papers citing papers by Atsushi Aoyagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Aoyagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Aoyagi. The network helps show where Atsushi Aoyagi may publish in the future.

Co-authorship network of co-authors of Atsushi Aoyagi

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Aoyagi. A scholar is included among the top collaborators of Atsushi Aoyagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Aoyagi. Atsushi Aoyagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model 2023 ·Nature Communications ·Noah R. Johnson, Peng Yuan, Erika Castillo, Theresa Lopez, (unknown), (unknown), (unknown), (unknown), Masakazu Hirouchi, Kurt Giles, Atsushi Aoyagi, Carlo Condello	28
2	Aβ and tau prions feature in the neuropathogenesis of Down syndrome 2022 ·Proceedings of the National Academy of Sciences ·Carlo Condello, Alison M. Maxwell, Erika Castillo, Atsushi Aoyagi, Caroline Graff, Martin Ingelsson, Lars Lannfelt, Thomas D. Bird, C. Dirk Keene, William W. Seeley, Daniel P. Perl, Elizabeth Head, Stanley B. Prusiner	17
3	Aβ and Tau Prions Causing Alzheimer’s Disease 2022 ·Methods in molecular biology ·Carlo Condello, Gregory E. Merz, Atsushi Aoyagi, William F. DeGrado, Stanley B. Prusiner	10
4	Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity 2020 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Atsushi Aoyagi, (unknown), (unknown), (unknown), Masakazu Hirouchi, Ryo Murakami, Joanne Lee, Koji Sasaki, (unknown), Takao Ohyama, Benjamin C. Tang, (unknown), Masahiro Inoue, Steven H. Olson, Stanley B. Prusiner, Jay C. Conrad, Nick A. Paras	10
5	Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain 2019 ·Science Translational Medicine ·Atsushi Aoyagi, Carlo Condello, Jan Stöhr, (unknown), (unknown), (unknown), Amanda L. Woerman, Glenda M. Halliday, Sjoerd G. van Duinen, Martin Ingelsson, Lars Lannfelt, Caroline Graff, Thomas D. Bird, C. Dirk Keene, William W. Seeley, William F. DeGrado, Stanley B. Prusiner	95
6	Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model 2019 ·The Journal of Physiological Sciences ·(unknown), Keita Kono, Futoshi Nara, Atsushi Aoyagi	3
7	α-Synuclein: Multiple System Atrophy Prions 2017 ·Cold Spring Harbor Perspectives in Medicine ·Amanda L. Woerman, Joel C. Watts, Atsushi Aoyagi, Kurt Giles, Lefkos Middleton, Stanley B. Prusiner	69
8	MSA prions exhibit remarkable stability and resistance to inactivation 2017 ·Acta Neuropathologica ·Amanda L. Woerman, Sabeen A. Kazmi, Smita S. Patel, Yevgeniy Freyman, Abby Oehler, Atsushi Aoyagi, Daniel A. Mordes, Glenda M. Halliday, Lefkos Middleton, Steve Gentleman, Steven H. Olson, Stanley B. Prusiner	73
9	Familial Parkinson’s point mutation abolishes multiple system atrophy prion replication 2017 ·Proceedings of the National Academy of Sciences ·Amanda L. Woerman, Sabeen A. Kazmi, Smita S. Patel, Atsushi Aoyagi, Abby Oehler, Kartika Widjaja, Daniel A. Mordes, Steven H. Olson, Stanley B. Prusiner	38
10	Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells 2016 ·Proceedings of the National Academy of Sciences ·Amanda L. Woerman, Atsushi Aoyagi, Smita S. Patel, Sabeen A. Kazmi, Iryna Lobach, Lea T. Grinberg, Ann C. McKee, William W. Seeley, Steven H. Olson, Stanley B. Prusiner	137
11	Propagation of prions causing synucleinopathies in cultured cells 2015 ·Proceedings of the National Academy of Sciences ·Amanda L. Woerman, Jan Stöhr, Atsushi Aoyagi, Ryan Rampersaud, (unknown), Joel C. Watts, Takao Ohyama, Smita S. Patel, Kartika Widjaja, Abby Oehler, David W. Sanders, Marc I. Diamond, William W. Seeley, Lefkos Middleton, Steve Gentleman, Daniel A. Mordes, Thomas C. Südhof, Kurt Giles, Stanley B. Prusiner	192
12	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling 2011 ·The Journal of Cell Biology ·Jason D. Berndt, Atsushi Aoyagi, (unknown), Jamie N. Anastas, Lan Tang, Randall T. Moon	80
13	Pharmacological Characterization of RS-1259, an Orally Active Dual Inhibitor of Acetylcholinesterase and Serotonin Transporter, in Rodents: Possible Treatment of Alzheimer’s Disease 2003 ·SHILAP Revista de lepidopterología ·Yasuyuki Abe, Atsushi Aoyagi, Takao Hara, (unknown), (unknown), Yoshihiro Kumagae, Shunji Naruto, Kazuo Koyama, Shinji Marumoto, Keiko Tago, Narihiro Toda, Kazuko Takami, (unknown), Mayuko Ori, Hiroshi Kogen, Tsugio Kaneko	0
14	A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease 2003 ·Bioorganic & Medicinal Chemistry ·Narihiro Toda, Keiko Tago, Shinji Marumoto, Kazuko Takami, Mayuko Ori, (unknown), Kazuo Koyama, Shunji Naruto, (unknown), (unknown), Takao Hara, Atsushi Aoyagi, Yasuyuki Abe, Tsugio Kaneko, Hiroshi Kogen	64
15	Design, synthesis and structure–Activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease 2003 ·Bioorganic & Medicinal Chemistry ·Narihiro Toda, Keiko Tago, Shinji Marumoto, Kazuko Takami, Mayuko Ori, (unknown), Kazuo Koyama, Shunji Naruto, (unknown), (unknown), Takao Hara, Atsushi Aoyagi, Yasuyuki Abe, Tsugio Kaneko, Hiroshi Kogen	31
16	Design and Synthesis of Dual Inhibitors of Acetylcholinesterase and Serotonin Transporter Targeting Potential Agents for Alzheimer's Disease 2002 ·Organic Letters ·Hiroshi Kogen, Narihiro Toda, Keiko Tago, Shinji Marumoto, Kazuko Takami, Mayuko Ori, (unknown), Kazuo Koyama, Shunji Naruto, (unknown), (unknown), Takao Hara, Atsushi Aoyagi, Yasuyuki Abe, Tsugio Kaneko	60
17	Early impairment and late recovery of synaptic transmission in the rat dentate gyrus following transient forebrain ischemia in vivo 1998 ·Brain Research ·Atsushi Aoyagi, Hiroshi Saito, Kazuho Abe, (unknown)	29
18	Differential Effects of Microtubule Inhibitors on Axonal Branching and Elongation of Cultured Rat Hippocampal Neurons 1995 ·The Japanese Journal of Pharmacology ·Atsushi Aoyagi, Hiroshi Saito, Kazuho Abe	3
19	Characterization of basic fibroblast growth factor-mediated acceleration of axonal branching in cultured rat hippocampal neurons 1994 ·Brain Research ·Atsushi Aoyagi, (unknown), (unknown), Kazuho Abe	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact